# Protect Pharmaceutical Corporation (PRTT)

> Industrials · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PRTT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 53.24M | $ 13.51M | $ -2.71M | $ 4.41M | $ 345.88M |
| 2024 | $ 139.02M | $ 59.20M | $ 10.35M | $ 3.83M | $ 332.69M |
| 2023 | $ 147.22M | $ 49.64M | $ 4.37M | $ 3.79M | $ 276.36M |
| 2022 | $ 11.1K | $ 5.8K | N/A | N/A | N/A |
| 2021 | $ 671.6K | $ 505.7K | $ 298.1K | $ 14.08M | $ 6.32M |
| 2020 | $ 7.57M | $ 7.41M | $ 725.6K | $ 14.08M | $ 5.89M |
| 2019 | $ 0 | $ -6.7K | N/A | N/A | N/A |
| 2018 | $ 0 | $ -10.8K | $ 95 | $ 121.0K | $ -151.6K |
| 2017 | $ 0 | $ -164.7K | $ 0 | $ 101.0K | $ -143.4K |
| 2016 | $ 0 | $ -57.4K | $ -19.5K | $ 0 | $ -20.8K |
| 2015 | $ 0 | $ -892.4K | $ -25.0K | $ 0 | $ -100.4K |
| 2014 | $ 0 | $ 647.4K | $ -253 | $ 0 | $ -121.0K |
| 2013 | $ 0 | $ -34.0K | $ -255 | $ 0 | $ -595.1K |
| 2012 | $ 0 | $ -800.3K | $ -30.9K | $ 0 | $ -577.2K |
| 2011 | $ 0 | $ -396.9K | $ 32.6K | $ 0 | $ -425.6K |
| 2010 | $ 0 | $ -10.64M | $ 0 | $ 0 | $ -459.2K |
| 2009 | N/A | N/A | N/A | $ 0 | $ -5.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.22 |
| Current Ratio | 3.37 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.60 |
| Gross Debt / FCF | 1.61 |

## Other views

- [Metrics](https://sponda.capital/en/PRTT.md)
- [Charts](https://sponda.capital/en/PRTT/charts.md)
- [Compare](https://sponda.capital/en/PRTT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.